BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Short (1M)
Kotak Securities Recommends 'Reduce' On Essel Propack
According to Kotak Securities, with the pharma regulatory framework in place, Essel Propack's business volumes in its India business are likely to grow in the coming quarters. However, the brokerage is of the view that given the recent run-up, the stock is trading at a fair valuation with limited upside.